KC-4923

293T-SMAD-Luc2-ACVR2A-KO Cell Line

×
Please enable JavaScript in your browser to complete this form.
53084
Home » 293T-SMAD-Luc2-ACVR2A-KO Cell Line

Background of 293T-SMAD-Luc2-ACVR2A-KO Cell Line

"ACVR2A gene also called ACVR2, ACTRII, or ACTRIIA is located on the long arm of chromosome 2 (location 2q22.2-q23.3) and has the overall length of 83.3 kb. The lead role of a protein encoded by this gene is the mediation of activin functions. The activin A receptor type 2A (ACVR2A) is constructed of 513 amino acids, and consists of an extracellular, a transmembrane and a cytoplasmic serine-threonine kinase domains. Except for the ability to transfer phosphate groups, the protein exhibits transferase and tyrosine kinase activity. "

Specifications

Catalog NumberKC-4923
Cell Line Name293T-SMAD-Luc2-ACVR2A-KO Cell Line
Clone Number1B3
Host Cell Line293T-SMAD-Luc2
DescriptionStable 293T-SMAD-Luc2 clone with human ACVR2A gene knockout, No.1B3
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing MediumDMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10% FBS+150μg/mL HygromycinB
Selection MarkerHygromycin B
Morphologyepithelial
SubcultureSplit saturated culture 1:5-1:8 every 2-3 days; seed out at about 1 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 40 hours
Mycoplasma StatusNegative

Cell Line Generation

293T-SMAD-Luc2-ACVR2A-KO cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of 293T-SMAD-Luc2-ACVR2A-KO cell line stable clone using PCR sequencing.

Figure 2: Characterization of 293T-SMAD-Luc2-ACVR2A-KO cell line stable clone using RT-PCR sequencing.

Figure 3: Characterization of 293T-SMAD-Luc2-ACVR2A-KO cell line stable clone using FACS.

Figure 4: 293T-SMAD-Luc2-ACVR2A-KO cells were seeded into 96-well plates, treated with Activin A for 16 hours, and then read out using Bright-Glo Detection System.

Figure 5: 293T-SMAD-Luc2-ACVR2A-KO cells were seeded into 96-well plates, treated with Bimagrumab (Cat# KB-1390, Kyinno) for 1 hours, and then treated with 50ng/mL Activin A for 16 hours, and then read out using Bright-Glo Detection System.

Cell Resuscitation

  1. Prewarm culture medium (DMEM + 10% FBS+150μg/mL HygromycinB) in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:5-1:8 every 2-3 days; seed out at about 1-3 ×105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Wodziński D, Wosiak A, Pietrzak J, Świechowski R, Jeleń A, Balcerczak E. Does the expression of the ACVR2A gene affect the development of colorectal cancer? Genet Mol Biol. 2019 Jan-Mar;42(1):32-39.
  2. Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM. Loss of Activin Receptor Type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology. 2004;126:654–659.
Please enable JavaScript in your browser to complete this form.